Table 1.
Placebo | Multivitamin | |
---|---|---|
(N=1006) | (N=1002) | |
Maternal characteristic | ||
Age (y) | 28.4±5.0a | 28.3±5.0 |
Education (%) | ||
<8 y | 80 | 78 |
≥8 y | 20 | 22 |
Employment (%) | ||
Housewife without income | 65 | 68 |
Housewife with income | 16 | 13 |
Others | 19 | 19 |
Possessions (%) | ||
Have a sofa | 74 | 72 |
Have a television | 41 | 41 |
Have a radio | 79 | 79 |
Have a refrigerator | 24 | 25 |
Daily food expenditure per person (%) | ||
≤500 T Shillingsb | 50 | 54 |
>500 T Shillings | 50 | 46 |
Marital status (%) | ||
Single | 13 | 13 |
Married/living with partner | 87 | 87 |
Prior pregnancies (%) | ||
0 | 22 | 22 |
1–3 | 70 | 70 |
>3 | 8 | 8 |
Gestational age at enrolment (wk) | 24.5±5.6 | 24.1±5.5 |
Body mass index (%) | ||
<18.5 kg/m2 | 4 | 4 |
18.5 – <25 kg/m2 | 55 | 57 |
25.0 – <30 kg/m2 | 31 | 30 |
≥30 kg/m2 | 10 | 9 |
Haemoglobin (%) | ||
<11 g/dL | 30 | 30 |
≥11 g/dL | 70 | 70 |
CD4+ count, cells/mm3 (%) | ||
<200 cells/mm3 | 9 | 9 |
200 – <350 cells/mm3 | 18 | 22 |
≥ 350 cells/mm3 | 73 | 68 |
WHO disease stage (%) | ||
I/II | 87 | 89 |
III/IV | 13 | 11 |
On anti-retroviral therapy during pregnancy (%) | 20 | 21 |
Child characteristics | ||
Male (%) | 53 | 54 |
Birth weight (kg) | 3.1±0.5 | 3.1±0.5 |
Low birth weight <2.5 kg (%) | 6 | 6 |
Prematurity, <37 weeks, (%) | 15 | 14 |
Weight at baseline (kg) | 4.5±0.7 | 4.5±0.7 |
Length/height-for-age z-score at baseline | −0.4 (1.3) | −0.3 (1.3) |
Weight-for-length/height z-score at baseline | −0.2 (1.3) | −0.1 (1.2) |
Weight-for-age z-score at baseline | −0.5 (1.1) | −0.4 (1.1) |
Haemoglobin at baseline (g/dL) | 10.4 (1.6) | 10.4 (1.5) |
Haemoglobin<10 g/dL (%) | 42 | 40 |
HIV positive at baseline (%) | 9 | 9 |
Received ART during study period (%) | 5 | 5 |
CD4+ percentage at baseline | 37.3 (10.4) | 37.5 (11.1) |
Duration of exclusive breastfeeding (months) | 3.5 (2.1) | 3.7 (2.1) |
Mean±standard deviation (all such values).
1250 T Shillings≈ 1 USD.